Mixed-infection of antibiotic susceptible and resistant Helicobacter pylori isolates in a single patient and underestimation of antimicrobial susceptibility testing

Helicobacter

Volumn 8, Issue 3, 2003, Pages 202-206

  Kim, Jae J ^a   Kim, Jong G ^b   Kwon, Dong H ^c,d  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Korea University College of Medicine   (South Korea)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Fingerprinting genotype; Helicobacter pylori; Heteroresistance; Mixed infection

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; BACTERIAL DNA; CLARITHROMYCIN; FURAZOLIDONE; METRONIDAZOLE; NITROFURANTOIN; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; COMORBIDITY; DNA FINGERPRINTING; GENOTYPE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; STOMACH ANTRUM; STOMACH BIOPSY;

ANTI-BACTERIAL AGENTS; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; GENOTYPE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MICROBIAL SENSITIVITY TESTS; PYLORIC ANTRUM; RANDOM AMPLIFIED POLYMORPHIC DNA TECHNIQUE;

BACTERIA (MICROORGANISMS); HELICOBACTER; HELICOBACTER PYLORI;

EID: 0037506894     PISSN: 10834389     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-5378.2003.00145.x     Document Type: Article

References (21)

1. Forman D, Newell DG, Fullerton F, et al. Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. BMJ 1991;302:1302-5.
2. Graham DY. Helicobacter pylori infection in the pathogenesis of duodenal ulcer and gastric cancer: a model. Gastroenterology 1997;113:1983-91.
3. NIH Consensus Conference, NIH Consensus Development panel on Helicobacter pylori in Peptic Ulcer Disease Helicobacter pylori in peptic ulcer disease. JAMA 1994;272:65 -9.
4. Parsonnet J, Friedman GD, Vandersteen DP, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991;325:1127-31.
5. Graham DY. Therapy of Helicobacter pylori: Current status and issues. Gastroenterology 2000;118:S2-8.
6. Kato M, Yamaoka Y, Kim JJ, et al. Regional differences in metronidazole resistance and increasing clarithromycin resistance among Helicobacter pylori isolates from Japan. Antimicrob Agents Chemother 2000;44:2214-6.
7. Kim JJ, Reddy R, Lee M, et al. Analysis of metronidazole, clarithromycin and tetracycline resistance of Helicobacter pylori isolates from Korea. J Antimicrob Chemother 2001;47:459-61.
8. Osato MS, Reddy R, Reddy SG, Penland RL, Malaty HM, Graham DY. Pattern of primary resistance of Helicobacter pylori to metronidazole or clarithromycin in the United States. Arch Intern Med 2001;161:1217-20.
9. Glupczynski Y, Megraud F, Lopez-Brea M, Andersen LP. European multicentre survey of in vitro antimicrobial resistance in Helicobacter pylori. Eur J Clin Microbiol Dis 2001;20:820-3.
10. Graham DY. Antibiotic resistance in Helicobacter pylori. Implications for Ther Gastroenterol 1998;115:1272-7.
11. Arents NL, Smeets LC, van Zwet AA, et al. Implications of the simultaneous presence of metronidazole-susceptible and -resistant Helicobacter pylori colonies within a single biopsy specimen. Eur J Clin Microbiol Infect Dis 2001; 20:418-20.
12. Hua J, Ling KL, Ng HS, Ho B. Isolation of a single strain of Helicobacter pylori from the antrum and body of individual patients. Eur J Gastroenterol Hepatol 2000;12:1129-34.
13. Hua J, Ng HC, Yeoh KG, Ho B. Predominance of a single strain of Helicobacter pylori in gastric antrum. Helicobacter 1999;4:28-32.
14. Ikezawa K, Kashimura H, Kojima M, et al. Pre-treatment antimicrobial susceptibilities of paired gastric Helicobacter pylori isolates: antrum versus corpus. Helicobacter 1999;4:218-21.
15. van der Ende A, van Doorn LJ, Rooijakkers S, Feller M, Tytgat GN, Dankert J. Clarithromycin-susceptible and - resistant Helicobacter pylori isolates with identical randomly amplified polymorphic DNA-PCR genotypes cultured from single gastric biopsy specimens prior to antibiotic therapy. J Clin Microbiol 2001;39:2648-51.
16. National Committee for Clinical Laboratory Standards. 2000. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically: Approved Standard, 5th edn. Villanova, PA: National Committee for Clinical Laboratory Standards.
17. Osato MS, Reddy R, Reddy SG, Penland RL, Graham DY. Comparison of the Etest and the NCCLS-approved agar dilution method to detect metronidazole and clarithromycin resistant Helicobacter pylori. Int J Antimicrob Agents 2001;17:39-44.
18. Kwon DH, Hulten K, Kato M, et al. DNA sequence analysis of rdxA and frxA from 12 pairs of metronidazole-sensitive and -resistant clinical Helicobacter pylori isolates. Antimicrob Agents Chemother 2001;45:2609-15.
19. Sisson G, Jeong JY, Goodwin A, et al. Metronidazole activation is mutagenic and causes DNA fragmentation in Helicobacter pylori and in Escherichia coli containing a cloned H. pylori RdxA (+) (Nitroreductase) gene. J Bacteriol 2000;182:5091-6.
20. Hayashi T, Makino K, Ohnishi M, et al. Complete genome sequence of enterohemorrhagic Escherichia coli O157: H7 and genomic comparison with a laboratory strain K-12. Nature 1997;388:539-47.
21. Tomb JF, White O, Kerlavage AR, et al. The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature 1997;388:539-47.